期刊文献+

信必可联合噻托溴铵吸入剂治疗重症哮喘的临床观察

下载PDF
导出
摘要 目的探讨信必可联合噻托溴铵吸入剂治疗重症哮喘的临床疗效。方法选取本科室治疗的重度哮喘患者60例,并按每组30例随机分为治疗组和对照组。治疗组予以信必可联合噻托溴铵吸入剂;对照组单纯予以噻托溴铵治疗。详细观察患者的肺功能变化情况;急性发作加重后的间隔时间,次数;生活质量等。结果治疗组总体有效率为90%,对照组总体有效率为60%。在急性发作后的支气管扩张试验,生活质量评分,治疗组均明显优于对照组(P<0.05)。结论信必可联合噻托溴铵吸入剂治疗重度哮喘疗效较好,能减少患者哮喘加重的频率,提高患者的生活质量。
作者 杨明生
出处 《中国卫生产业》 2013年第16期79-80,共2页 China Health Industry
  • 引文网络
  • 相关文献

参考文献6

二级参考文献49

  • 1丁敏娇,戴元荣.糖皮质激素防治支气管哮喘患者气道重塑的研究进展[J].中华结核和呼吸杂志,2005,28(9):656-658. 被引量:19
  • 2郭胤仕,许以平,徐艳华.粉尘螨抗原对支气管哮喘患者外周血单个核细胞T-bet和GATA3及FOXP3 mRNA表达水平的影响[J].中华结核和呼吸杂志,2007,30(2):112-115. 被引量:3
  • 3National institutes of health,National heart,Lung and Blood Institute.Global strategy for asthma management and prevention.Revised,2006,http://www.ginasthma.com/Guidelineitem.asp.
  • 4Bateman ED,Boushey HA,Bousquet J,et al.Can guideline-defined asthma control be achieved? The Gaining Optimal Asthma ControL study.Am J Respir Crit Care Med,2004,170:836-844.
  • 5van den Toom LM,Overbeek SE,de Jongste JC,et al.Airway inflammation is present during clinical remission of atopic asthma.Am J Respir Crit Care Med,2001,164:2107-2113.
  • 6Bateman ED,Jacques L,Goldfrad C,et al.Asthma control can be maintained when fluticasone propionate/salmeteml in a single inhaler is stepped down.J Allergy Clin Immunol,2006,117:563-570.
  • 7Woolcock AJ.Jenkins CR.Assessment of bronchial responsiveness as a guide to prognosis and therapy in asthlna.Med Clin North Am,1990,74:753-765.
  • 8Rabe KF,Atienza T,Magyar P,et al.Effect of budesonide in combination with formoterol for reliever therapy in asthma exacerbations:a randomised controlled,double-blind study.Lancet,2006,368:744-753.
  • 9杨锡强.儿科学,2003.
  • 10Umetsu DT;Akbari O;Dekruyff RH.Regulatory T cells control the development of allergic disease and asthma[J],2003(03).

共引文献6084

;
使用帮助 返回顶部